Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
VCEL
VCEL
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
VCEL News
Regenerative Medicine Market Rapid Expansion
2d ago
Newsfilter
Rapid Expansion of the Regenerative Medicine Market
2d ago
Globenewswire
Conexeu Sciences Advances Wound Care Technology
4d ago
Globenewswire
Conexeu Sciences Advances Wound Care Technology with Regulatory Progress
4d ago
Newsfilter
Vericel Corporation to Present at 2026 Truist Securities MedTech Conference
Jun 09 2026
Newsfilter
Soleus Capital Increases Stake in Vericel
May 30 2026
NASDAQ.COM
Soleus Capital Increases Stake in Vericel Significantly
May 30 2026
Fool
Conexeu Sciences Inc. Goes Public, Pioneering a New Era in Regenerative Medicine
May 22 2026
Globenewswire
Conexeu Sciences Inc. Goes Public, Pioneering a New Era in Regenerative Medicine
May 22 2026
Newsfilter
Vericel Corporation Reports Record Q1 2026 Earnings with Increased Guidance
May 08 2026
seekingalpha
Vericel Q1 Earnings Beat Expectations with Strong Revenue Growth
May 07 2026
seekingalpha
Vericel Scheduled to Announce Q1 Earnings on May 7
May 06 2026
seekingalpha
Cell Therapy Market Set to Nearly Double by 2035
Apr 06 2026
Newsfilter
Vericel Secures $197M Contract with U.S. BARDA
Apr 02 2026
seekingalpha
Vericel Secures $197 Million BARDA Contract
Apr 02 2026
Newsfilter
MediWound Reports $197 Million BARDA Contract Award to Vericel for NexoBrid
Apr 02 2026
Newsfilter
Show More News
